This article is more than 5 years old. Information may no longer be current.
Wright Medical Group appoints new president of U.S. extremities
Click Here to Manage Email Alerts
Wright Medical Group recently announced that Kevin D. Cordell was appointed president of U.S. extremities, effective Sept. 29, 2014. Cordell will be responsible for operations for the Wright Medical U.S. extremities and biologic business and will report to the chief operating officer.
Robert Palmisano, Wright Medical president and chief executive officer, stated in a company press release, “Kevin is an accomplished senior executive with a demonstrated history of leading direct sales organizations and developing fast-growing, underpenetrated markets, and I’m delighted to welcome him to the Wright management team. His deep experience and strong capabilities will be instrumental as we continue to drive our success in our U.S. extremities and biologics markets.”
Pascal Girin, Wright Medical executive vice president and chief operating officer, stated in the press release, “For over 20 years, Kevin has led the development, implementation, and execution of successful commercial strategies and programs for global medical device, biotech and pharmaceutical companies. His proven track record of success and his passion for building high performing commercial organizations will serve us well as we continue to focus on accelerating revenue growth, driving sales rep productivity gains in our U.S. foot and ankle business, and launching new products, in particular our new INFINTY ankle.”
Before joining Wright Medical Group, Cordell was vice president of sales for GI Solutions at Covidien and held such positions as vice president of global sales, vice president of sales and global marketing and vice president of U.S. sales for various companies.